Moreover, the molecules such as p-ERK, p-AKT, and Bcl-2 in tumor tissues were all down-regulated, whereas Bax was up-regulated in response to trimebutine treatment, which was consistent with in vitro results we observed. The gene discussed is BCL2; the disease is neoplasm.